photodynamic_therapy_criteria
Defines medical necessity criteria and coding guidance for photodynamic therapy (PDT) for commercial products, specifying covered indications (nonhyperkeratotic actinic keratoses of face/scalp and upper extremities; select low-risk BCC and Bowen disease when surgery/radiation contraindicated), noncovered cosmetic/other dermatologic uses, and associated CPT/HCPCS/J-codes and ICD-10 diagnosis codes.
No material change
Coverage Summary
Defines medical necessity criteria and coding guidance for photodynamic therapy (PDT) for commercial products: covered indications include nonhyperkeratotic actinic keratoses of the face and scalp and nonhyperkeratotic actinic keratoses of the upper extremities; select low-risk basal cell carcinoma (superficial and nodular) and Bowen disease (cutaneous squamous cell carcinoma in situ) when surgery and radiation are contraindicated. Also specifies associated covered CPT/HCPCS/J-codes and appropriate ICD-10 diagnosis codes and states that other dermatologic or cosmetic uses are not medically necessary or have insufficient evidence.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.